← Back to headlines
GSK Reports Strong Q2 2026 Earnings and Launches Cost-Savings Plan
Pharmaceutical company GSK announced better-than-expected earnings for the second quarter of 2026 and unveiled a new £1.9 billion cost-savings initiative.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
